Page last updated: 2024-08-17

androstenedione and Cancer of Prostate

androstenedione has been researched along with Cancer of Prostate in 129 studies

Research

Studies (129)

TimeframeStudies, this research(%)All Research%
pre-199049 (37.98)18.7374
1990's30 (23.26)18.2507
2000's12 (9.30)29.6817
2010's31 (24.03)24.3611
2020's7 (5.43)2.80

Authors

AuthorsStudies
Djigoué, GB; Kenmogne, LC; Maltais, R; Poirier, D; Roy, J1
Chu, L; Chu, T; Ge, M; Huang, Y; Lu, Q; Shu, X1
Caron, P; Guillemette, C; Lacombe, L; Lévesque, É; Morin, F; Neveu, B; Pouliot, F; Rouleau, M; Toren, P; Turcotte, V1
Chung, YM; McManus, JM; Sharifi, N1
Beamud-Cortés, M; Bermell-Marco, L; Cauli, O; Mafla-España, MA; Rubio-Briones, J; Torregrosa, MD1
Caron, P; Ding, K; Guillemette, C; Klotz, L; Lacombe, L; Lévesque, É; Morin, F; Neveu, B; Pouliot, F; Rouleau, M; Toren, P; Vélot, L1
Adomat, H; Chin, MY; Deb, S; Gleave, ME; Hurtado-Coll, A; Pham, S; Tomlinson Guns, ES1
Bérubé, G; Oufqir, Y; Paquin, A; Reyes-Moreno, C; Sevrioukova, IF1
Abderrahman, B; Jordan, VC1
Alyamani, M; Berk, M; Hettel, D; Sharifi, N; Zhang, A1
du Toit, T; Gent, R; Swart, AC1
Kikuchi, E; Kosaka, T; Maeda, T; Miyajima, A; Nagata, H; Oya, M1
Azen, CG; Pike, MC; Stanczyk, FZ1
Chen, HL; Du, JJ; Li, YC1
O'Hanlon, LH1
Arnold, JT; Piao, YS; Sprando, R; Wiesenfeld, P1
Morgentaler, A; Traish, AM1
Stanczyk, FZ1
Bloem, LM; Schloms, L; Storbeck, KH; Swart, AC1
Audenet, F; Murez, T; Neuzillet, Y; Ripert, T; Villers, A1
Adomat, H; Beheshti, EH; Chin, MY; Deb, S; Guns, ET; Kharmate, G; Locke, J; Ming, DS; Pham, S1
Corcoran, NM; Costello, AJ; Fankhauser, M; Haviv, I; Hong, MK; Hovens, CM; Macintyre, G; Nguyen, A; Pedersen, JS; Tan, Y1
Azami, H; Baskin-Bey, E; Enjo, K; Furutani, T; Heeringa, M; Kamiyama, Y; Kikuchi, A; Kuromitsu, S; Niimi, T; Ouatas, T; Watanabe, K1
Knudsen, KE1
Auchus, RJ; Sharifi, N1
Corcoran, NM; Hong, MK; Hovens, CM1
Andrew, R; Faqehi, AM; Homer, NZ; Hughes, KA; Naredo, G; Stewart, LH; Upreti, R; Walker, BR1
Ambrosone, CB; Figg, WD; Goodman, PJ; Hoque, A; Hsing, AW; Kristal, AR; Lippman, SM; Neuhouser, ML; Parnes, HL; Platz, EA; Price, DK; Reichardt, JK; Santella, RM; Stanczyk, FZ; Tangen, CM; Thompson, IM; Till, C; vanBokhoven, A; Yao, S1
Anai, S; Fujimoto, K; Miyake, M; Nakai, Y; Tanaka, N; Tatsumi, Y1
de Jong, FH; Dits, NF; Hofland, J; Jenster, G; Schröder, FH; Steenbergen, J; van Leenders, GJ; van Weerden, WM1
Ahlem, C; Bell, D; Delorme, E; Frincke, J; Kennedy, M; Page, T; Reading, C; Stickney, D; Villegas, S; White, S1
Arai, S; Honma, S; Kobayashi, M; Miyashiro, Y; Shibata, Y; Suzuki, K; Tomaru, Y1
Chanock, SJ; Chokkalingam, AP; Chu, LW; Hayes, RB; Hsing, AW; Huang, WY; Kaaks, R; Li, Q; Menashe, I; Meyer, TE; Quraishi, SM; Rosenberg, PS; Weiss, JM; Yu, K1
Balk, SP; Bubley, GJ; Cai, C; Chen, S; Marck, B; Matsumoto, AM; Mostaghel, EA; Nelson, PS; Ng, P; Simon, NI; Wang, H1
Boevé, E; Bui, HN; de Ronde, W; Hartman, JF; Heijboer, AC; Meuleman, EJ; van Adrichem, N; van der Sluis, TM; van Moorselaar, RJ; Vis, AN1
Auchus, RJ; Chang, KH; Evaul, K; Li, R; Liu, J; Sharifi, N; Sharma, KK; Yoshimoto, J1
Arai, S; Hashimoto, K; Honma, S; Ito, K; Kashiwagi, B; Miyashiro, Y; Nakamura, Y; Sasano, H; Sekine, Y; Shibata, Y; Suzuki, K; Tomaru, Y; Uei, T1
Hartmann, MF; Kamrath, C; Wudy, S1
Broeder, CE1
Barnett, MJ; Chen, C; DiTommaso, D; Etzioni, R; Goodman, GE; Lewis, SK; Stanczyk, FZ; Weiss, NS1
Ford, OH; French, FS; Gregory, CW; Kim, D; Mohler, JL; Petrusz, P; Weaver, CM; Wilson, EM1
Bai, C; Chen, F; Freedman, L; Gambone, C; Harada, S; Kasparcova, V; Knecht, K; Leu, C; Reszka, A; Rutledge, SJ; Scafonas, A; Schmidt, A; Vogel, R; Zhang, H1
Habuchi, T; Kakinuma, H; Kato, T; Matsuura, S; Nakamura, A; Ohyama, C; Tsuchiya, N; Wang, L1
Attar, RM; Fink, BE; Gottardis, MM; Kick, EK; Lawrence, RM; Lorenzi, MV; Rizzo, CA; Ruan, Z; Salvati, ME; Spires, TE; Takenaka, I; Vite, GD; Weinmann, R; You, D1
Andriole, GL; Chatterjee, N; Crawford, ED; Fears, TR; Hayes, RB; Hsing, AW; Huang, WY; Kaaks, R; Rinaldi, S; Weiss, JM1
Carpenter, WR; Godley, PA; Robinson, WR1
Allen, NE; Appleby, P; Key, TJ; Roddam, AW1
Habib, FK1
Ghanadian, R; Masters, JR; Smith, CB1
Chilvers, CE; Dowsett, M; Easton, D; Jeffcoate, SL; Miller, J; Pocock, RD; Ponder, BA; Shearer, RJ1
Trachtenberg, J1
Hammond, GL; Kontturi, M; Lukkarinen, O; Vihko, R1
Ghanadian, R; Masters, JR; Metcalfe, SA; Smith, CB1
Marks, TA; Petrow, V1
Hammond, GL; Leinonen, P; Vihko, R1
Chisholm, GD; Elton, RA; Habib, FK; Halliday, P; Rana, A; Ross, M; Wild, R1
Geller, J1
McTavish, D; Wiseman, LR1
Bartsch, G; Cato, AC; Cronauer, MV; Culig, Z; Eberle, J; Hittmair, A; Hobisch, A; Klocker, H; Radmayr, C1
Hakky, SI; Hudson, PB; Lombardo, ME2
Boccardo, F; Decensi, A; Marroni, P; Padovani, P; Pensa, F; Torrisi, R1
Adami, HO; Andersson, SO; Bergström, R; Wide, L1
Carsol, JL; Délos, S; Ghazarossian, E; Martin, PM; Raynaud, JP1
Block, JL; Block, NL; Lokeshwar, BL1
Bartsch, G; Cato, AC; Culig, Z; Gast, A; Hittmair, A; Hobisch, A; Klocker, H; Peterziel, H; Radmayr, C; Stober, J1
di Salle, E; Giudici, D; Zaccheo, T1
Balk, SP; Bubley, GJ; Fenton, MA; Fertig, AM; Kolvenbag, G; Shuster, TD; Taplin, ME1
Aho, K; Hakama, M; Heikkilä, R; Heliövaara, M; Knekt, P; Marniemi, J; Reunanen, A1
Colciago, A; Motta, M; Negri-Cesi, P; Poletti, A1
Chang, C; Miyamoto, H1
Albanes, D; Barrett, MJ; Dorgan, JF; Hartman, TJ; Heinonen, OP; Tangrea, JA; Taylor, PR; Virtamo, J; Woodson, K1
Le Lain, R; Maharlouie, FH; Nicholls, PJ; Smith, HJ1
Habib, FK; Stitch, SR1
Attramadal, A; Djöseland, O; Hansson, V; Naess, O; Torgersen, O; Tveter, KJ; Weddington, SC1
Habib, FK; Lee, IR; Smith, PH; Stitch, SR1
Attramadal, A; Djoseland, O; Hansson, V; Naess, O; Weddington, SC1
Bard, DR; Lasnitzki, I1
Hammond, GL; Kontturi, M; Vihko, P; Vihko, R1
Schweikert, HU1
Siiteri, PK; Walsh, PC1
Di Silverio, F; Gagliardi, V; Sciarra, F; Sorcini, G2
Brownsey, BG; Cowley, TH; Griffiths, K; Harper, ME; Peeling, WB1
Attramadal, A; Hansson, V; Haugen, HN; Kjoseland, O; Mathisen, W; Tveter, KJ1
Rodriguez-Rigau, LJ; Smith, KD; Steinberger, E; Tcholakian, RK1
McCullough, B; Nitchuk, WM; Shain, SA1
Cavazos, LF; Charles, JF; Floch, HH; Leav, I; Morfin, RF; Ofner, P1
Hammond, GL; Kontturi, M; Koskela, E; Ruokonen, A; Vihko, R1
Halpern, ME; Kelch, RP; Musich, SS; Payne, AH1
Brownsey, BG; Cowley, T; Fahmy, DR; Griffiths, K; Groom, G; Harper, ME; Peeling, WB; Phillips, ME1
Albert, J; Geller, J; Geller, S; Lopez, D1
Davies, JH; Heeremans, CE; Jarman, M; McCague, R; Niessen, WM; Poon, GK; van der Greef, J; van der Hoeven, RA1
de Jong, FH; Elissen, NM; Schröder, FH; van Kreuningen, A; van Steenbrugge, GJ; van Weerden, WM1
Coombes, RC; Davies, JH; Dowsett, M; Hedley, A; Jacobs, S; Shearer, RJ1
Hudson, RW; Wherrett, D1
Davies, JH; Dowsett, M; Rowlands, MG; Shearer, RJ1
Cooper, MR; Danesi, R; Ewing, MW; Jamis-Dow, CA; La Rocca, RV; Linehan, WM; Myers, CE1
de Jong, FH; Moerings, EP; Schröder, FH; van Kreuningen, A; van Steenbrugge, GJ; van Weerden, WM1
Bartsch, G; Graf, AH; Hartmann, H; Klocker, H; Schiller, CD; Schneider, MR1
Bélanger, A; Brochu, M; Caron, S; Couture, J; Cusan, L; Dupont, A; Labrie, F; Lacoste, D; Noël, C1
Ayub, M; Levell, MJ1
Abel, PD; Asopa, R; Smith, C; Williams, G1
Carlström, K; Stege, R1
Coombes, RC; Cunningham, D; Davies, JH; Dowsett, M; Hedley, A; Malone, PR; Shearer, RJ1
Banks, PK; Brodie, AM; Inkster, SE; Koos, RD; Son, C1
Barrett-Connor, E; Garland, C; Khaw, KT; McPhillips, JB; Wingard, DL1
Cocconi, M; Martini, L; Motta, M; Serio, M; Zoppi, S1
Cummings, KB; Havlin, KH; Jordan, VC; Lange, PH; Messing, EM; Trump, DL1
Brodie, AM; Inkster, SE; King, DA; Meyer, KM; Son, C1
Carlström, K; Collste, L; Eriksson, A; Henriksson, P; Pousette, A; Stege, R; von Schoultz, B1
Bongini, M; Bozzolan, F; Doukani, A; Mauvais-Jarvis, P; Poizat, R; Wright, F1
Bressel, M; Kastendieck, H; Klein, H; Voigt, KD1
Al-Sarraf, M; Decker, DA; Kresge, C; Subramanian, MG; Tapazoglou, E1
Amery, W; Beerens, D; Caers, I; Coene, MC; De Coster, R; Haelterman, C1
Carlström, K; Eriksson, A; Henriksson, P; Stege, R1
Trachtenberg, J; Zadra, J1
Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F1
Dowsett, M; Jeffcoate, SL; Malone, P; Ponder, BA; Shearer, RJ1
Ahmann, FR; Crawford, ED; Kreis, W; Levasseur, Y1
Fair, WR; Fishman, J; Laudone, VP; Stone, NN1
Berg, AA; Daehlin, L; Damber, JE; Hammar, M; Petersson, F1
Marts, SA; Padilla, GM; Petrow, V1
Allen, J; Bloom, SR; Doble, A; Dunlop, H; Kerle, DJ; Smith, C; Ware, H; Williams, G; Yeo, T1
Chaban, M; Denis, L; Mahler, C1
Bertagna, C; Coussedière, D; Husson, JM; Moguilewsky, M; Pendyala, L; Pottier, J; Raynaud, JP; Salmon, J; Tournemine, C; Tremblay, D1
Ochiai, K; Oshima, H; Sarada, T; Tamaoki, B1
Cavazos, LF; Leav, I; Ofner, P1
Altwein, JE; Hohenfellner, R; Orestano, F1

Reviews

9 review(s) available for androstenedione and Cancer of Prostate

ArticleYear
[Advances in the study of steroidal inhibitors of cytochrome P45017alpha].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:1

    Topics: Androstenedione; Androstenes; Androstenols; Animals; Antineoplastic Agents; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Humans; Male; Molecular Structure; Pregnenolone; Progesterone; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Testosterone

2013
11β-hydroxyandrostenedione returns to the steroid arena: biosynthesis, metabolism and function.
    Molecules (Basel, Switzerland), 2013, Oct-25, Volume: 18, Issue:11

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; Male; Prostatic Neoplasms; Steroid 11-beta-Hydroxylase

2013
[CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23 Suppl 1

    Topics: Abiraterone Acetate; Adjuvants, Immunologic; Androgens; Androstadienes; Androstenedione; Antineoplastic Agents; Dehydroepiandrosterone; Disease Progression; Humans; Male; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Treatment Outcome

2013
[The alternative androgen synthesis pathway in humans].
    Klinische Padiatrie, 2013, Volume: 225, Issue:1

    Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Androgens; Androstenedione; Animals; Child; Child, Preschool; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Pregnancy; Prostatic Neoplasms; Sex Differentiation; Steroid 21-Hydroxylase; Testis; Testosterone

2013
Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits?
    Canadian journal of applied physiology = Revue canadienne de physiologie appliquee, 2003, Volume: 28, Issue:1

    Topics: Androstenediol; Androstenediols; Androstenedione; Dietary Supplements; Estrogens; Humans; Lipoproteins, HDL; Male; Muscle, Skeletal; Prostatic Neoplasms; Risk Factors; Sexual Behavior; Testosterone

2003
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
    Journal of the National Cancer Institute, 2008, Feb-06, Volume: 100, Issue:3

    Topics: Aged; Androgens; Androstenediols; Androstenedione; Case-Control Studies; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Glucuronides; Gonadal Steroid Hormones; Humans; Logistic Models; Male; Middle Aged; Prostatic Neoplasms; Research Design; Risk Assessment; Risk Factors; Sex Hormone-Binding Globulin; Testosterone

2008
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.
    Drugs, 1993, Volume: 45, Issue:1

    Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; In Vitro Techniques; Male; Prostatic Neoplasms

1993
Androgen binding and metabolism in the human prostate.
    Vitamins and hormones, 1975, Volume: 33

    Topics: Androgens; Androstanes; Androstenedione; Animals; Cytosol; Dihydrotestosterone; Humans; Male; Muscles; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Binding; Rats; Receptors, Cell Surface; Testosterone

1975
Aromatase and other inhibitors in breast and prostatic cancer.
    The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Humans; Male; Prostatic Neoplasms

1990

Trials

13 trial(s) available for androstenedione and Cancer of Prostate

ArticleYear
Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy.
    The Journal of urology, 2020, Volume: 203, Issue:5

    Topics: Anabolic Agents; Androgens; Androstenedione; Biomarkers, Tumor; Castration; Cell Line, Tumor; Follow-Up Studies; Humans; Male; Mass Spectrometry; Neoplasm Recurrence, Local; Prospective Studies; Prostate; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Time Factors

2020
Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    The Journal of steroid biochemistry and molecular biology, 2013, Volume: 138

    Topics: 5-alpha Reductase Inhibitors; Aged; Androstane-3,17-diol; Androstenedione; Dihydrotestosterone; Finasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone

2013
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.
    Urology, 2015, Volume: 85, Issue:3

    Topics: Androstenedione; Case-Control Studies; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Neoplasm Grading; Prostatic Neoplasms; Risk Assessment

2015
A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide.
    Hormones & cancer, 2015, Volume: 6, Issue:4

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Flutamide; Humans; Male; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds

2015
17α-alkynyl 3α, 17β-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism.
    Investigational new drugs, 2012, Volume: 30, Issue:1

    Topics: Administration, Oral; Androstanols; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Biotransformation; Cell Line, Tumor; Chromatography, Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; Dogs; Drug Administration Schedule; Enzyme Induction; Enzyme Inhibitors; Female; Humans; Macaca fascicularis; Male; Metabolomics; Mice; Microsomes, Liver; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Species Specificity; Tandem Mass Spectrometry; Testosterone; Transcriptional Activation; Transfection

2012
Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    International journal of cancer, 2008, May-15, Volume: 122, Issue:10

    Topics: Aged; Androstenedione; Case-Control Studies; Cohort Studies; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Sex Hormone-Binding Globulin; Surveys and Questionnaires; Testosterone

2008
A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:6

    Topics: Androgen Antagonists; Androstenedione; Bromocriptine; Humans; Hydrocortisone; Male; Orchiectomy; Prolactin; Prospective Studies; Prostatic Neoplasms; Treatment Outcome

1995
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion.
    The Prostate, 1994, Volume: 24, Issue:1

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Androgen Antagonists; Androgens; Androstenedione; Antineoplastic Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Triptorelin Pamoate

1994
Effects of long-term alpha-tocopherol supplementation on serum hormones in older men.
    The Prostate, 2001, Jan-01, Volume: 46, Issue:1

    Topics: Alcohol Drinking; Androstenedione; Cholesterol; Dehydroepiandrosterone; Eating; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Prolactin; Prostatic Neoplasms; Radioimmunoassay; Regression Analysis; Sex Hormone-Binding Globulin; Smoking; Testosterone; Vitamin E

2001
Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.
    British journal of cancer, 1992, Volume: 66, Issue:1

    Topics: Aged; Androstenedione; Aromatase Inhibitors; Dihydrotestosterone; Estradiol; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Testosterone; Time Factors

1992
Pituitary adrenal and gonadal endocrine suppression for the primary treatment of prostate cancer.
    British journal of urology, 1990, Volume: 65, Issue:5

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dexamethasone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testosterone

1990
Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone.
    Urologia internationalis, 1990, Volume: 45, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adrenal Cortex; Adrenocorticotropic Hormone; Androstenedione; Combined Modality Therapy; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Injections, Intramuscular; Male; Orchiectomy; Prostatic Neoplasms; Serum Albumin; Steroid 16-alpha-Hydroxylase; Testosterone

1990
Aromatase inhibition in advanced prostatic cancer: preliminary communication.
    British journal of cancer, 1990, Volume: 62, Issue:2

    Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Clinical Trials as Topic; Humans; Male; Middle Aged; Prostatic Neoplasms

1990

Other Studies

107 other study(ies) available for androstenedione and Cancer of Prostate

ArticleYear
Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.
    Bioorganic & medicinal chemistry, 2015, Sep-01, Volume: 23, Issue:17

    Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Animals; Carbamates; Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Humans; Male; Morpholines; Prostate; Prostatic Neoplasms; Rats; Spiro Compounds

2015
Sex steroid hormones in urinary exosomes as biomarkers for the prediction of prostate cancer.
    Clinica chimica acta; international journal of clinical chemistry, 2022, Jun-01, Volume: 531

    Topics: Androstenedione; Biomarkers; Dehydroepiandrosterone; Dihydrotestosterone; Exosomes; Humans; Male; Prostatic Neoplasms; Tandem Mass Spectrometry; Testosterone

2022
Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level.
    The Journal of urology, 2022, Volume: 208, Issue:6

    Topics: Androgen Antagonists; Androgens; Androstenedione; Androsterone; Dehydroepiandrosterone; Dihydrotestosterone; Estrone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sulfates; Testosterone

2022
3βHSD activity saturates at physiological substrate concentrations in intact cells.
    The Prostate, 2023, Volume: 83, Issue:13

    Topics: Androgens; Androstenediols; Androstenedione; Cell Line, Tumor; Dehydroepiandrosterone; Humans; Male; Placenta; Pregnancy; Prostatic Neoplasms

2023
Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy.
    Biomolecules, 2023, Nov-13, Volume: 13, Issue:11

    Topics: Aged; Androgen Antagonists; Androgens; Androstenedione; Dehydroepiandrosterone; Frail Elderly; Frailty; Humans; Male; Prostatic Neoplasms; Testosterone

2023
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue.
    International journal of molecular sciences, 2021, Jan-06, Volume: 22, Issue:2

    Topics: Androstenedione; Androsterone; Chromatography, High Pressure Liquid; Humans; Male; Mass Spectrometry; Progesterone; Prostate; Prostatic Neoplasms; Steroids; Testosterone

2021
Innovative C
    European journal of medicinal chemistry, 2021, Aug-05, Volume: 220

    Topics: Androstenedione; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytochrome P-450 CYP3A; Dimerization; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Prostatic Neoplasms; Recombinant Proteins; Structure-Activity Relationship; Testosterone; Tumor Cells, Cultured

2021
Angela M. Hartley Brodie (1934-2017).
    Nature, 2017, 08-02, Volume: 548, Issue:7665

    Topics: Androstadienes; Androstenedione; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Estrogens; Female; History, 20th Century; History, 21st Century; Humans; Male; Maryland; Prostatic Neoplasms

2017
AR Signaling in Prostate Cancer Regulates a Feed-Forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation.
    Endocrinology, 2018, 08-01, Volume: 159, Issue:8

    Topics: Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Benzamides; Cell Line, Tumor; Dehydroepiandrosterone; Gene Expression Regulation, Neoplastic; Humans; Male; Metribolone; Mice; Multienzyme Complexes; Neoplasm Transplantation; Nitriles; Orchiectomy; Phenylthiohydantoin; Progesterone Reductase; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Steroid Isomerases; Testosterone; Testosterone Congeners; Up-Regulation

2018
11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro.
    The Journal of steroid biochemistry and molecular biology, 2019, Volume: 191

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Androstenedione; Cell Line, Tumor; Cortodoxone; HEK293 Cells; Humans; Hydroxyprogesterones; Male; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase

2019
Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity.
    Scientific reports, 2013, Volume: 3

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Carbon Isotopes; Castration; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Coculture Techniques; Dihydrotestosterone; Humans; Male; Membrane Proteins; Prostatic Neoplasms; RNA, Messenger; Tandem Mass Spectrometry; Testosterone

2013
Studying the connection between exercise and cancer risk reduction.
    Journal of the National Cancer Institute, 2013, Jun-05, Volume: 105, Issue:11

    Topics: Androstenedione; Biomarkers; Breast Neoplasms; Colonic Neoplasms; Diet, Reducing; Endometrial Neoplasms; Estrogens; Exercise; Female; Humans; Inflammation; Male; Motor Activity; Neoplasms; Obesity; Ovarian Neoplasms; Physical Exertion; Prostatic Neoplasms; Risk Assessment; Risk Factors; Risk Reduction Behavior; Sex Hormone-Binding Globulin

2013
TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment?
    The Journal of steroid biochemistry and molecular biology, 2013, Volume: 138

    Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Androstenedione; Cell Line, Tumor; Dehydroepiandrosterone; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxysteroid Dehydrogenases; Male; Prostate; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Stromal Cells; Testosterone; Transforming Growth Factor beta1

2013
Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    The Journal of steroid biochemistry and molecular biology, 2013, Volume: 138

    Topics: 5-alpha Reductase Inhibitors; Androstenedione; Finasteride; Humans; Male; Prostatic Neoplasms; Testosterone

2013
Response to commentary.
    The Journal of steroid biochemistry and molecular biology, 2013, Volume: 138

    Topics: 5-alpha Reductase Inhibitors; Androstenedione; Finasteride; Humans; Male; Prostatic Neoplasms; Testosterone

2013
Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.
    The Journal of steroid biochemistry and molecular biology, 2014, Volume: 143

    Topics: Androgens; Androstenedione; Animals; Blotting, Western; Cell Proliferation; Dihydrotestosterone; Humans; In Vitro Techniques; Lythraceae; Male; Mice; Mice, Knockout; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; PTEN Phosphohydrolase; Receptors, Androgen; Testosterone; Tumor Cells, Cultured

2014
Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Nov-01, Volume: 20, Issue:21

    Topics: 3-Hydroxysteroid Dehydrogenases; Aged; Aged, 80 and over; Aldo-Keto Reductase Family 1 Member C3; Androgens; Androstenedione; Estradiol Dehydrogenases; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Middle Aged; Prostate; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Up-Regulation

2014
In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).
    Investigational new drugs, 2014, Volume: 32, Issue:5

    Topics: Administration, Oral; Androstenedione; Animals; Biological Availability; Cell Line, Tumor; Dogs; Enzyme Inhibitors; Estradiol Dehydrogenases; Humans; Indoles; Macaca fascicularis; Male; Mice, Inbred BALB C; Piperidines; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Testosterone

2014
Hormone whodunit: clues for solving the case of intratumor androgen production.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Nov-01, Volume: 20, Issue:21

    Topics: Androgens; Androstenedione; Humans; Male; Prostatic Neoplasms

2014
Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Sep-15, Volume: 20, Issue:18

    Topics: Androgen Antagonists; Androgens; Androstenedione; Drug Resistance, Neoplasm; Humans; Male; Prostatic Neoplasms

2014
Androstenedione is the preferred androgen source in hormone refractory prostate cancer--response.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Sep-15, Volume: 20, Issue:18

    Topics: Androgens; Androstenedione; Drug Resistance, Neoplasm; Humans; Male; Prostatic Neoplasms

2014
Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry.
    Talanta, 2015, Volume: 131

    Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenedione; Azasteroids; Chromatography, Liquid; Dihydrotestosterone; Dutasteride; Finasteride; Humans; Male; Prostatic Neoplasms; Solid Phase Extraction; Tandem Mass Spectrometry; Testosterone; Tissue Distribution

2015
Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.
    Cancer research, 2010, Feb-01, Volume: 70, Issue:3

    Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Aged, 80 and over; Aldo-Keto Reductase Family 1 Member C3; Androgens; Androstenedione; Animals; Cell Line, Tumor; Dihydrotestosterone; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Mice; Middle Aged; Neoplasms, Experimental; Orchiectomy; Pregnenolone; Progesterone Reductase; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Testosterone; Transplantation, Heterologous

2010
Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues.
    Steroids, 2011, Volume: 76, Issue:3

    Topics: Adrenal Glands; Androgens; Androstenediol; Androstenedione; Castration; Chromatography, Liquid; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Neoplasms

2011
The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.
    The Prostate, 2012, Volume: 72, Issue:1

    Topics: Aged; Alleles; Androgens; Androstenedione; Case-Control Studies; Gene Frequency; Genetic Association Studies; Genotype; Humans; Inflammation; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Testosterone

2012
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.
    Cancer research, 2011, Oct-15, Volume: 71, Issue:20

    Topics: Androstenedione; Androstenes; Androstenols; Animals; Antineoplastic Agents, Hormonal; Carcinoma; Cell Line, Tumor; Dehydroepiandrosterone; Female; Humans; Indomethacin; Male; Mice; Orchiectomy; Pregnenolone; Progesterone; Prostatic Neoplasms; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Up-Regulation

2011
Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.
    The Journal of urology, 2012, Volume: 187, Issue:5

    Topics: Aged; Aged, 80 and over; Androstenedione; Castration; Chromatography, Liquid; Dehydroepiandrosterone Sulfate; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Sex Hormone-Binding Globulin; Tandem Mass Spectrometry; Testosterone

2012
Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jul-01, Volume: 18, Issue:13

    Topics: 3-Hydroxysteroid Dehydrogenases; Abiraterone Acetate; Active Transport, Cell Nucleus; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Cell Line, Tumor; Dehydroepiandrosterone; Dihydrotestosterone; Drug Resistance, Neoplasm; Humans; Isoenzymes; Male; Mice; Mice, Inbred NOD; Mice, SCID; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Tumor Burden; Xenograft Model Antitumor Assays

2012
Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues.
    Andrology, 2013, Volume: 1, Issue:1

    Topics: Aged; Androstenedione; Dihydrotestosterone; Disease Progression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Hypogonadism; Immunohistochemistry; Male; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone

2013
Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:12

    Topics: Age Distribution; Aged; Androstenedione; Antioxidants; Biomarkers, Tumor; Carotenoids; Case-Control Studies; Confidence Intervals; Estradiol; Gonadal Steroid Hormones; Humans; Incidence; Male; Middle Aged; Odds Ratio; Probability; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Reference Values; Risk Assessment; Sensitivity and Specificity; Sex Hormone-Binding Globulin; Testosterone; Vitamin A

2003
The androgen axis in recurrent prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-15, Volume: 10, Issue:2

    Topics: Aged; Aged, 80 and over; Androgens; Androstenedione; Antibodies, Monoclonal; Cell Nucleus; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Microscopy, Video; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Receptors, Androgen; Recurrence

2004
Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
    The Journal of steroid biochemistry and molecular biology, 2004, Volume: 91, Issue:4-5

    Topics: Adaptor Proteins, Signal Transducing; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Androstenediol; Androstenedione; Anilides; Animals; Breast Neoplasms; Carrier Proteins; Cell Division; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dihydrotestosterone; Humans; Ligands; Macaca mulatta; Male; Mammary Tumor Virus, Mouse; Mice; Nerve Tissue Proteins; Nitriles; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, AMPA; Receptors, Androgen; Tosyl Compounds; Transcription, Genetic; Tumor Cells, Cultured

2004
Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.
    Prostate cancer and prostatic diseases, 2004, Volume: 7, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Aged, 80 and over; Androgens; Androstenedione; Biomarkers, Tumor; Cohort Studies; DNA, Neoplasm; Genotype; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors; Steroid 17-alpha-Hydroxylase; Testosterone

2004
Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3).
    The Prostate, 2005, Oct-01, Volume: 65, Issue:2

    Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Anti-Inflammatory Agents; Drug Evaluation, Preclinical; Glycyrrhetinic Acid; Humans; Male; ortho-Aminobenzoates; Prostatic Neoplasms; Testosterone

2005
Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer.
    Journal of the National Cancer Institute, 2008, Feb-06, Volume: 100, Issue:3

    Topics: Androgens; Androstenediols; Androstenedione; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Glucuronides; Gonadal Steroid Hormones; Humans; Male; Meta-Analysis as Topic; Prostatic Neoplasms; Research Design; Risk Factors; Testosterone

2008
Evaluation of androgen metabolism studies in human prostate cancer--correlation with zinc levels.
    Preventive medicine, 1980, Volume: 9, Issue:5

    Topics: Aged; Androgens; Androstenedione; Carcinoma; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Zinc

1980
Altered androgen metabolism in carcinoma of the prostate.
    European urology, 1981, Volume: 7, Issue:3

    Topics: Androstenediols; Androstenedione; Culture Techniques; Dihydrotestosterone; Male; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1981
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
    British journal of cancer, 1984, Volume: 50, Issue:6

    Topics: Adenocarcinoma; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Cortisone; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Neoplasms; Sleep Stages; Testosterone

1984
Ketoconazole therapy in advanced prostatic cancer.
    The Journal of urology, 1984, Volume: 132, Issue:1

    Topics: Acid Phosphatase; Aged; Androstenedione; Dehydroepiandrosterone; Follow-Up Studies; Humans; Ketoconazole; Male; Prostatic Neoplasms; Testosterone; Time Factors

1984
Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
    Investigative urology, 1980, Volume: 17, Issue:4

    Topics: Aged; Androstenedione; Androsterone; Castration; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Humans; Hydroxyprogesterones; Male; Middle Aged; Organophosphorus Compounds; Pregnenolone; Progesterone; Prostatic Neoplasms; Steroids; Testosterone

1980
Androgen metabolism by human prostatic tumours in organ culture.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:7

    Topics: Androstenedione; Dihydrotestosterone; Humans; Male; NADPH Dehydrogenase; Organ Culture Techniques; Oxidation-Reduction; Prostatic Neoplasms; Testosterone

1983
Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
    Cancer research, 1983, Volume: 43, Issue:8

    Topics: Adenocarcinoma; Androstenedione; Animals; Diethylstilbestrol; Estradiol; Male; Organ Size; Prostate; Prostatic Neoplasms; Rats

1983
Testosterone and some of its precursors and metabolites in the human epididymis.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 51, Issue:3

    Topics: Aged; Androstane-3,17-diol; Androstenedione; Androsterone; Dihydrotestosterone; Epididymis; Estrogens; Humans; Hydroxyprogesterones; Male; Middle Aged; Pregnenolone; Progesterone; Prostatic Neoplasms; Testis; Testosterone; Vas Deferens

1980
Basis for hormonal management of advanced prostate cancer.
    Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl

    Topics: Androstenedione; Animals; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Biosynthesis; Rats; Testosterone

1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Molecular endocrinology (Baltimore, Md.), 1993, Volume: 7, Issue:12

    Topics: Adrenal Glands; Aged; Amino Acid Sequence; Androgen Antagonists; Androstenedione; Animals; Base Sequence; Carcinoma; Cell Line; Chlorocebus aethiops; Cloning, Molecular; Dehydroepiandrosterone; Dihydrotestosterone; DNA, Complementary; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Male; Molecular Sequence Data; Neoplasm Proteins; Point Mutation; Polymerase Chain Reaction; Progesterone; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Steroids; Transcriptional Activation

1993
Testicular androgens in prostate cancer patients treated with a luteinizing hormone releasing hormone agonist.
    The Journal of urology, 1994, Volume: 151, Issue:5

    Topics: 17-Hydroxysteroid Dehydrogenases; Aged; Aged, 80 and over; Androgens; Androstenedione; Humans; Leuprolide; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testis; Testosterone

1994
Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study.
    British journal of cancer, 1993, Volume: 68, Issue:1

    Topics: Age Factors; Aged; Androstenedione; Case-Control Studies; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Neoplasm Staging; Prostatic Neoplasms; Registries; Sex Hormone-Binding Globulin; Sweden; Testosterone

1993
In vitro studies on the inhibition of testosterone synthesis in the human testis by atamestane.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:3

    Topics: 17-Hydroxysteroid Dehydrogenases; Aged; Androstenedione; Binding, Competitive; Humans; In Vitro Techniques; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testis; Testosterone

1993
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4

    Topics: 17-Hydroxysteroid Dehydrogenases; Adenosarcoma; Androstenedione; Azasteroids; Blotting, Northern; Cells, Cultured; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Dihydrotestosterone; Enzyme Inhibitors; Epithelium; Etiocholanolone; Fibroblasts; Finasteride; Humans; Male; Meningioma; Oxidoreductases; Placenta; Prostatic Neoplasms; RNA; RNA, Messenger; Testosterone; Tumor Cells, Cultured

1995
Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
    Cancer letters, 1996, Mar-29, Volume: 101, Issue:2

    Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Cell Division; Culture Media, Serum-Free; Drug Screening Assays, Antitumor; Humans; Male; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured

1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Cancer detection and prevention, 1996, Volume: 20, Issue:1

    Topics: Androgens; Androstenedione; Androsterone; Animals; Base Sequence; Blood Proteins; Complement C4; DNA, Neoplasm; Haplorhini; Humans; Male; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Transcriptional Activation; Transfection

1996
Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
    The Prostate, 1997, Feb-01, Volume: 30, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Leuprolide; Luteinizing Hormone; Male; Organ Size; Pituitary Gland, Anterior; Prostate; Prostatic Neoplasms; Random Allocation; Rats; Seminal Vesicles; Testis; Testosterone

1997
Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:8

    Topics: Amino Acid Substitution; Androgen Antagonists; Androgens; Androstenedione; Animals; beta-Galactosidase; Cell Line; Dihydrotestosterone; Estradiol; Flutamide; Genes, Reporter; Imidazoles; Imidazolidines; Luciferases; Male; Point Mutation; Progesterone; Prostatic Neoplasms; Receptors, Androgen; Recombinant Fusion Proteins; Transfection

1997
Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
    Cancer, 1999, Jul-15, Volume: 86, Issue:2

    Topics: Aged; Androstenedione; Biomarkers, Tumor; Carcinoma; Case-Control Studies; Humans; Longitudinal Studies; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone

1999
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    The Prostate, 1999, Dec-01, Volume: 41, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Southern; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Humans; Hydrogen-Ion Concentration; Isoenzymes; Male; Microsomes; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Triazoles; Tumor Cells, Cultured

1999
Antiandrogens fail to block androstenedione-mediated mutated androgen receptor transactivation in human prostate cancer cells.
    International journal of urology : official journal of the Japanese Urological Association, 2000, Volume: 7, Issue:1

    Topics: Androgen Antagonists; Androstenedione; Humans; Male; Mutation; Prostatic Neoplasms; Receptors, Androgen; Transcriptional Activation; Tumor Cells, Cultured

2000
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
    Journal of enzyme inhibition, 2001, Volume: 16, Issue:1

    Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Benzoquinones; Drug Evaluation, Preclinical; Enzyme Inhibitors; Estradiol; Estrone; Flavanones; Flavonoids; Genistein; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Kinetics; Male; Microsomes; Prostatic Neoplasms; Rats; Structure-Activity Relationship; Testis; Testosterone

2001
Letter: Hormones, elderly testes, and carcinoma of the prostate.
    British medical journal, 1975, Dec-13, Volume: 4, Issue:5997

    Topics: Androgens; Androstenedione; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1975
Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
    The Journal of endocrinology, 1976, Volume: 71, Issue:1

    Topics: Aged; Androgens; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1976
Androgen receptors in male sex tissues of rats and humans.
    Progress in clinical and biological research, 1976, Volume: 6

    Topics: Androstane-3,17-diol; Androstenedione; Animals; Dihydrotestosterone; Epididymis; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Androgen; Receptors, Steroid; Testis; Testosterone

1976
The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    The Journal of endocrinology, 1977, Volume: 74, Issue:1

    Topics: Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1977
Serum steroids in normal males and patients with prostatic diseases.
    Clinical endocrinology, 1978, Volume: 9, Issue:2

    Topics: Adult; Aged; Aging; Androstenedione; Androsterone; Dihydrotestosterone; Estradiol; Humans; Hydroxyprogesterones; Male; Middle Aged; Pregnenolone; Progesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Reference Values; Steroids; Testosterone

1978
Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1979, Volume: 11, Issue:11

    Topics: Adolescent; Adult; Aged; Androstenedione; Cells, Cultured; Estrone; Fibroblasts; Humans; Kinetics; Male; Middle Aged; Penis; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Skin

1979
Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.
    The Journal of urology, 1975, Volume: 114, Issue:2

    Topics: Aged; Androgens; Androstenedione; Castration; Dehydroepiandrosterone; Depression, Chemical; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Spironolactone; Testosterone

1975
Biosynthesis and metabolism of androgenic hormones in cancer of the prostate.
    Investigative urology, 1976, Volume: 13, Issue:4

    Topics: Adenocarcinoma; Androgens; Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Prostatic Neoplasms; Testosterone

1976
The effect of ACTH on plasma testosterone and androstenedione concentrations in patients with prostatic carcinoma.
    Acta endocrinologica, 1976, Volume: 81, Issue:2

    Topics: Adrenocorticotropic Hormone; Androstenedione; Cosyntropin; Cross Reactions; Diethylstilbestrol; Humans; Male; Prostatic Neoplasms; Stimulation, Chemical; Testosterone

1976
Metabolism of testosterone in the human prostate and seminal vesicles.
    Scandinavian journal of urology and nephrology, 1977, Volume: 11, Issue:1

    Topics: Adenocarcinoma; Androstanes; Androstenedione; Androsterone; Culture Techniques; Humans; Hyperplasia; Male; Prostate; Prostatic Neoplasms; Seminal Vesicles; Testosterone

1977
In vitro steroid metabolic studies in human testes. II: Metabolism of cholesterol, pregnenolone, progesterone, androstenedione and testosterone by testes of an estrogen-treated man.
    Steroids, 1977, Volume: 30, Issue:6

    Topics: Adult; Androgens; Androstenedione; Cholesterol; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Humans; Male; Pregnenolone; Progesterone; Progestins; Prostatic Neoplasms; Testis; Testosterone; Transsexualism

1977
C19-steroid metabolism by spontaneous adenocarcinoma of the A X C rat ventral prostate.
    Journal of the National Cancer Institute, 1977, Volume: 58, Issue:3

    Topics: 17-Ketosteroids; Adenocarcinoma; Androstenedione; Animals; Dihydrotestosterone; Hydroxysteroids; Hyperplasia; Male; Neoplasms, Experimental; Prostatic Neoplasms; Rats; Testosterone

1977
Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue.
    Cancer, 1977, Volume: 39, Issue:4

    Topics: Androgens; Androstane-3,17-diol; Androstenedione; Carcinoma, Transitional Cell; Dihydrotestosterone; Humans; Hyperplasia; In Vitro Techniques; Male; Prostate; Prostatic Neoplasms; Testosterone

1977
The simultaneous radioimmunoassay of seven steroids in human spermatic and peripheral venous blood.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 45, Issue:1

    Topics: Adult; Aged; Androstenedione; Androsterone; Dihydrotestosterone; Hormones; Humans; Male; Middle Aged; Pregnenolone; Progesterone; Prostatic Neoplasms; Radioimmunoassay; Steroids; Testis; Testosterone

1977
Intratesticular site of aromatization in the human.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 42, Issue:6

    Topics: Adult; Aged; Androstenedione; Estradiol; Estrone; Humans; Infant; Male; Middle Aged; Prostatic Neoplasms; Testis; Testosterone

1976
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.
    Acta endocrinologica, 1976, Volume: 81, Issue:2

    Topics: Aged; Androstenedione; Carcinoma; Estradiol; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Prolactin; Prostatic Neoplasms; Steroids; Testosterone

1976
A method for tissue extraction and determination of prostate concentrations of endogenous androgens by radioimmunoassay.
    Journal of immunological methods, 1976, Volume: 12, Issue:3-4

    Topics: Androgens; Androstane-3,17-diol; Androstenedione; Dihydrotestosterone; Humans; Kidney; Male; Methods; Prostate; Prostatic Neoplasms; Radioimmunoassay; Spleen; Testosterone

1976
Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometry.
    Journal of chromatography, 1992, May-08, Volume: 576, Issue:2

    Topics: Androstenedione; Chromatography, High Pressure Liquid; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Prostatic Neoplasms; Spectrophotometry, Ultraviolet

1992
Effects of adrenal androgens on the transplantable human prostate tumor PC-82.
    Endocrinology, 1992, Volume: 131, Issue:6

    Topics: Androstenedione; Animals; Bromodeoxyuridine; Cell Division; Dehydroepiandrosterone; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured

1992
Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
    Journal of steroid biochemistry, 1990, Volume: 35, Issue:2

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Cell Fractionation; Cell Nucleus; Humans; Kinetics; Male; NADP; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1990
Comparison of aromatase activity in human prostatic, testicular and placental tissues.
    Journal of enzyme inhibition, 1991, Volume: 4, Issue:4

    Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Carcinoma; Female; Humans; Male; Microsomes; Placenta; Pregnancy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Testis; Tissue Distribution

1991
Effect of suramin on human prostate cancer cells in vitro.
    The Journal of urology, 1991, Volume: 145, Issue:2

    Topics: Adenocarcinoma; Androstenedione; Antineoplastic Agents; Cell Line; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; In Vitro Techniques; Male; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured

1991
Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.
    Urological research, 1991, Volume: 19, Issue:1

    Topics: Adenocarcinoma; Androstenedione; Animals; Awards and Prizes; Castration; Dehydroepiandrosterone; Europe; Humans; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Societies, Medical; Testosterone; Urology

1991
Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma.
    Urological research, 1991, Volume: 19, Issue:1

    Topics: Adenocarcinoma; Androstenedione; Animals; Castration; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Stimulation, Chemical

1991
Steroid glucuronides: human circulatory levels and formation by LNCaP cells.
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 40, Issue:4-6

    Topics: Adolescent; Adult; Aging; Androstane-3,17-diol; Androstenedione; Child; Child, Preschool; Dehydroepiandrosterone; Glucuronates; Humans; Male; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Sulfates; Tumor Cells, Cultured

1991
Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue.
    Clinical endocrinology, 1990, Volume: 32, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androgens; Androstenedione; Anilides; Antineoplastic Agents; Buserelin; Dehydroepiandrosterone; Depression, Chemical; Flutamide; Goserelin; Humans; Hydroxyprogesterones; Male; Orchiectomy; Prostatic Neoplasms; Testosterone

1990
A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
    Cancer research, 1990, Jan-01, Volume: 50, Issue:1

    Topics: Adult; Aged; Androstenedione; California; Cohort Studies; Estradiol; Estrone; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Reference Values; Risk Factors; Sex Hormone-Binding Globulin; Surveys and Questionnaires; Testosterone

1990
New approaches for the treatment of prostatic hypertrophy and cancer.
    Hormone research, 1987, Volume: 28, Issue:2-4

    Topics: Aged; Androgens; Androstenedione; Animals; Carbon Radioisotopes; Humans; Kinetics; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Inbred Strains

1987
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Acid Phosphatase; Aged; Aged, 80 and over; Androstenedione; Antigens, Neoplasm; Biomarkers, Tumor; Diethylstilbestrol; Drug Evaluation; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Testicular Hormones; Testosterone

1989
Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
    Cancer research, 1989, Dec-01, Volume: 49, Issue:23

    Topics: Androstenedione; Aromatase; Cholestenone 5 alpha-Reductase; Estrogens; Humans; In Vitro Techniques; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1989
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy.
    The Prostate, 1989, Volume: 14, Issue:2

    Topics: Administration, Oral; Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrogens; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone

1989
Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstane-3,17-diol; Androstanols; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1985
Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
    American journal of clinical oncology, 1988, Volume: 11 Suppl 2

    Topics: 17-Hydroxysteroid Dehydrogenases; Adrenal Glands; Androgens; Androstenediols; Androstenedione; Arylsulfatases; Cholestenone 5 alpha-Reductase; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Humans; Lymphatic Metastasis; Male; Neoplasms, Hormone-Dependent; Oxidoreductases; Prostate; Prostatic Neoplasms; Steryl-Sulfatase; Testosterone

1988
High-dose ketoconazole therapy in patients with metastatic prostate cancer.
    American journal of clinical oncology, 1986, Volume: 9, Issue:5

    Topics: Adenocarcinoma; Aged; Androstenedione; Combined Modality Therapy; Dehydroepiandrosterone; Dexamethasone; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Humans; Ketoconazole; Luteinizing Hormone; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Testosterone

1986
Effects of high dose ketoconazole therapy on the main plasma testicular and adrenal steroids in previously untreated prostatic cancer patients.
    Clinical endocrinology, 1986, Volume: 24, Issue:6

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Aged; Androgens; Androstenedione; Corticosterone; Cortodoxone; Dehydroepiandrosterone; Desoxycorticosterone; Humans; Hydroxyprogesterones; Ketoconazole; Male; Progesterone; Prostatic Neoplasms; Testosterone

1986
Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids.
    International journal of andrology, 1987, Volume: 10, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrogens; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Serum Albumin; Steroids

1987
Steroid synthesis inhibition by ketoconazole: sites of action.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Aged; Aldehyde-Lyases; Androgens; Androstenedione; Chorionic Gonadotropin; Cosyntropin; Cytochrome P-450 Enzyme Inhibitors; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Hydroxyprogesterones; Ketoconazole; Male; Progesterone; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Testosterone

1988
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate

1988
The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.
    British journal of cancer, 1988, Volume: 57, Issue:2

    Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Humans; Hydrocortisone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone; Time Factors

1988
Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
    Cancer research, 1987, Sep-01, Volume: 47, Issue:17

    Topics: Aminoglutethimide; Androgens; Androstenedione; Drug Therapy, Combination; Humans; Hydrocortisone; Male; Orchiectomy; Prostatic Neoplasms; Testosterone

1987
Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions.
    Urological research, 1987, Volume: 15, Issue:3

    Topics: Androstenedione; Carrier Proteins; Dose-Response Relationship, Drug; Estrogens; Humans; Hyperplasia; Male; Prostate; Prostatic Neoplasms; Prostatic Secretory Proteins

1987
Effects of oestradiol-17 beta and ethinyl oestradiol on human testicular steroidogenesis in vitro.
    Scandinavian journal of urology and nephrology, 1986, Volume: 20, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Estradiol; Ethinyl Estradiol; Humans; Hydroxyprogesterones; In Vitro Techniques; Male; Middle Aged; Orchiectomy; Progesterone; Prostatic Neoplasms; Radioimmunoassay; Testis; Testosterone

1986
Aromatase activity in microsomes from rat ventral prostate and Dunning R3327H rat prostatic adenocarcinoma.
    Journal of steroid biochemistry, 1987, Volume: 26, Issue:1

    Topics: Adenocarcinoma; Age Factors; Androstenedione; Animals; Aromatase; Estrogens; Male; Microsomes; Prostate; Prostatic Neoplasms; Rats

1987
Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer.
    British journal of urology, 1986, Volume: 58, Issue:1

    Topics: Acid Phosphatase; Aged; Androstenedione; Humans; Ketoconazole; Male; Middle Aged; Prostatic Neoplasms; Testosterone; Time Factors

1986
Clinical applications of ketoconazole in prostatic cancer.
    Progress in clinical and biological research, 1985, Volume: 185A

    Topics: Androstenedione; Humans; Ketoconazole; Male; Prostatic Neoplasms; Testosterone

1985
Pharmacology and clinical studies with RU 23908 (Anandron).
    Progress in clinical and biological research, 1985, Volume: 185A

    Topics: Androgen Antagonists; Androstenedione; Animals; Castration; Diethylstilbestrol; Flutamide; Humans; Imidazoles; Imidazolidines; Kinetics; Male; Organ Size; Prostate; Prostatic Neoplasms; Rats

1985
Effects of a synthetic estrogen upon steroid bioconversion in vitro in testes of patients with prostatic cancer.
    Investigative urology, 1974, Volume: 12, Issue:1

    Topics: 17-alpha-Hydroxypregnenolone; Administration, Oral; Aged; Androstenedione; Enzyme Repression; Hexestrol; Humans; Hydroxyprogesterones; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Isomerases; Lyases; Male; Middle Aged; Mixed Function Oxygenases; NADP; Progesterone; Prostatic Neoplasms; Spermatogenesis; Steroids; Testis; Testosterone

1974
Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinoma.
    Clinical endocrinology, 1973, Volume: 2, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenocarcinoma; Adrenal Glands; Aged; Androstenedione; Castration; Dexamethasone; Humans; Male; Middle Aged; Prostatic Neoplasms; Testis; Testosterone; Time Factors

1973
Fine structure and C19-steroid metabolism of spontaneous adenocarcinoma of the canine prostate.
    Journal of the National Cancer Institute, 1974, Volume: 52, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adenocarcinoma; Androstenedione; Animals; Carbon Radioisotopes; Castration; Dogs; Lymph Nodes; Male; Microscopy, Electron; Neoplasms, Experimental; Organoids; Oxidation-Reduction; Prostate; Prostatic Neoplasms; Testosterone

1974
Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
    Investigative urology, 1974, Volume: 12, Issue:2

    Topics: Androstenediols; Androstenedione; Depression, Chemical; Dihydrotestosterone; Gestonorone Caproate; Humans; In Vitro Techniques; Kinetics; Male; Progesterone; Prostatic Neoplasms; Testosterone; Tritium

1974